Distinct clinicopathological features and prognosis of emerging young-female breast cancer in an east Asian country: A nationwide cancer registry-based study

Oncologist

Volumn 19, Issue 6, 2014, Pages 583-591

  Lin, Ching Hung ^a   Chuang, Po Ya ^b   Chiang, Chun Ju ^c,d   Lu, Yen Shen ^a   Cheng, Ann Lii ^a   Kuo, Wen Hung ^a   Huang, Chiun Sheng ^a   Lai, Mei Shu ^c,d,e   You, San Lin ^d,f,g   Tang, Chao Hsiun ^b  

^a NATIONAL TAIWAN UNIVERSITY HOSPITAL   (Taiwan)

^b TAIPEI MEDICAL UNIVERSITY   (Taiwan)

^c NATIONAL TAIWAN UNIVERSITY   (Taiwan)

^d School of Health Care Administration Taipei Medical University ^*  (Taiwan)

^e National Center of Excellence for Clinical Trials and Research   (Taiwan)

^f GENOMICS RESEARCH CENTER   (Taiwan)

^g FU JEN CATHOLIC UNIVERSITY   (Taiwan)

Author keywords

Asia; Breast cancer; Estrogen; Young

Indexed keywords

ADOLESCENT; ADULT; AGE; AGED; ARTICLE; AXILLARY LYMPH NODE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER HORMONE THERAPY; CANCER PROGNOSIS; CANCER REGISTRY; CANCER RISK; CANCER STAGING; CLINICAL FEATURE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; ESTROGEN RECEPTOR POSITIVE BREAST CANCER; FEMALE; HAZARD RATIO; HISTOLOGY; HUMAN; MAJOR CLINICAL STUDY; MIDDLE AGED; OUTCOME ASSESSMENT; PATHOLOGY; PRIORITY JOURNAL; PROGESTERONE RECEPTOR POSITIVE BREAST CANCER; TUMOR VOLUME; VERY ELDERLY; BREAST NEOPLASMS; FAR EAST; REGISTER;

ADULT; AGE FACTORS; AGED; BREAST NEOPLASMS; DISEASE-FREE SURVIVAL; FAR EAST; FEMALE; HUMANS; MIDDLE AGED; NEOPLASM STAGING; REGISTRIES;

EID: 84901927747     PISSN: 10837159     EISSN: 1549490X     Source Type: Journal    
DOI: 10.1634/theoncologist.2014-0047     Document Type: Article

References (30)

1. Sim X, Ali RA, Wedren S et al. Ethnic differences in the time trend of female breast cancer incidence: Singapore, 1968-2002. BMC Cancer 2006;6:261
2. Yoo KY, Kim Y, Park SK et al. Lifestyle, genetic susceptibility and future trends of breast cancer in Korea. Asian Pac J Cancer Prev 2006;7:679-682
3. Matsuno RK, Anderson WF, Yamamoto S et al. Early-and late-onset breast cancer types among women in the United States and Japan. Cancer Epidemiol Biomarkers Prev 2007;16:1437-1442
4. Shen YC, Chang CJ, Hsu C et al. Significant difference in the trends of female breast cancer incidence between Taiwanese and Caucasian Americans: Implications fromage-period-cohort analysis. Cancer Epidemiol Biomarkers Prev 2005;14: 1986-1990
5. Porter P. "Westernizing" women's risks? Breast cancer in lower-income countries. N Engl J Med 2008;358:213-216
6. Chung M, Chang HR, Bland KI et al. Younger women with breast carcinoma have a poorer prognosis than older women. Cancer 1996;77:97-103
7. Anders CK, Hsu DS, Broadwater G et al. Young age at diagnosis correlates with worse prognosis and defines a subset of breast cancers with shared patterns of gene expression. J Clin Oncol 2008;26: 3324-3330
8. Azim HA Jr., Michiels S, Bedard PL et al. Elucidating prognosis and biology of breast cancer arising in young women using gene expression profiling. Clin Cancer Res 2012;18:1341-1351
9. Lin CH, Liau JY, Lu YS et al. Molecular subtypes of breast cancer emerging in young women in Taiwan: Evidence for more than just westernization as a reason for the disease in Asia. Cancer Epidemiol Biomarkers Prev 2009;18:1807-1814
10. Nixon AJ, Neuberg D, Hayes DF et al. Relationship of patient age to pathologic features of the tumor and prognosis for patients with stage I or II breast cancer. J Clin Oncol 1994;12:888-894
11. Walker RA, Lees E, Webb MB et al. Breast carcinomas occurring in young women (,35 years) are different. Br J Cancer 1996;74:1796-1800
12. Anderson WF, Chu KC, Chatterjee N et al. Tumor variants by hormone receptor expression in white patients with node-negative breast cancer from the Surveillance, Epidemiology, and End Results database. J Clin Oncol 2001;19:18-27
13. Olivotto IA, Bajdik CD, Ravdin PM et al. Population-based validation of the prognostic model ADJUVANT! for early breast cancer. J Clin Oncol 2005;23:2716-2725
14. Ravdin PM, Siminoff LA, Davis GJ et al. Computer program to assist in making decisions about adjuvant therapy forwomen with early breast cancer. J Clin Oncol 2001;19:980-991
15. Deshpande AD, Jeffe DB, Gnerlich J et al. Racial disparities in breast cancer survival: An analysis by age and stage. J Surg Res 2009;153:105-113
16. Rosenberg J, Chia YL, Plevritis S. The effect of age, race,tumorsize,tumorgrade,and disease stage on invasive ductal breast cancer survival in the U.S. SEER database. Breast Cancer Res Treat 2005;89: 47-54
17. Colleoni M, Rotmensz N, Robertson C et al. Very young women (< 35 years) with operable breast cancer: Features of disease at presentation. Ann Oncol 2002;13:273-279
18. Bertheau P, Steinberg SM, Merino MJ. C-erbB-2, p53, and nm23 gene product expression in breast cancer in young women: Immunohistochemical analysis and clinicopathologic correlation. Hum Pathol 1998;29:323-329
19. Caldarella A, Crocetti E, Bianchi S et al. Female breast cancer status according to ER, PR and HER2 expression: A population based analysis. Pathol Oncol Res 2011;17:753-758
20. Piccart-Gebhart MJ, Procter M, Leyland-Jones B et al. Trastuzumab after adjuvant chemotherapy in HER2-positive breast cancer. N Engl J Med 2005; 353:1659-1672
21. Romond EH, Perez EA, Bryant J et al. Trastuzumab plus adjuvant chemotherapy for operable HER2-positive breast cancer. N Engl J Med 2005; 353:1673-1684
22. Lin CH, Chen YC, Chiang CJ et al. The emerging epidemic of estrogen-related cancers in young women in a developing Asian country. Int J Cancer 2012;130:2629-2637
23. Chu WW. Import substitution and export-led growth: A study of Taiwan's petrochemical industry. World Dev 1994;22:781-794
24. Lu YY, Chen ML, Sung FC et al. Daily intake of 4-nonylphenol in Taiwanese. Environ Int 2007;33: 903-910
25. Chen ML, Chen JS, Tang CL et al. The internal exposure of Taiwanese to phthalate-an evidence of intensive use of plastic materials. Environ Int 2008;34:79-85
26. Chen ML, Lee HY, Chuang HY et al. Association between nonylphenol exposure and development of secondary sexual characteristics. Chemosphere 2009;76:927-931
27. Chen CY, Wen TY, Wang GS et al. Determining estrogenic steroids in Taipei waters and removal in drinking water treatment using high-flow solidphase extraction and liquid chromatography/ tandem mass spectrometry. Sci Total Environ 2007; 378:352-365
28. Fang GC, Wu YS, Fu PP et al. Polycyclic aromatic hydrocarbons in the ambient air of suburban and industrial regions of central Taiwan. Chemosphere 2004;54:443-452
29. Yager JD, Davidson NE. Estrogen carcinogenesis in breast cancer. N Engl J Med 2006;354: 270-282
30. Huang CS, Lin CH, Lu YS et al. Unique features of breast cancer in Asian women-breast cancer in Taiwan as an example. J Steroid Biochem Mol Biol 2010;118:300-303.